Research
Hormonal
Tirzepatide consistently showed reductions in HbA1c and benefits with weight loss in clinical trials.
Tirzepatide is effective for improving glycemic control and promoting weight loss in type 2 diabetes patients.
StrongSupportsmedium confidence
Tirzepatide consistently showed reductions in HbA1c, as well as benefits with weight loss.
Why this rating
Based on pivotal phase 3 trial results.
Source
Tirzepatide: A Dual Glucose-dependent Insulinotropic Polypeptide and Glucagon-Like Peptide-1 Agonist for the Management of Type 2 Diabetes Mellitus
Elaine Wong et al. · American Journal of Therapeutics · 2022
reviewCited 8×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →